RUNX1 Regulates a Transcription Program That Affects the Dynamics of Cell Cycle Entry of Naive Resting B Cells

Area of Science:

• Immunology
• Molecular Biology
• Cell Biology

Background:

• RUNX1 is a crucial transcription factor in hematopoietic development.
• B cell receptor (BCR) signaling is vital for B cell activation and immune responses.

Purpose of the Study:

• To investigate the role of RUNX1 in regulating gene expression and cell cycle dynamics in naive mouse B cells following BCR stimulation.
• To elucidate the molecular mechanisms by which RUNX1 controls B cell activation.

Main Methods:

• Conditional knockout of the Runx1 gene in mouse resting B cells.
• Analysis of gene expression changes (e.g., Ccnd2, Fosl2, Atf3, Egr2, Rbpj, Cd22, Bank1, Ifnar1) after BCR stimulation.
• Chromatin immunoprecipitation assays to study protein-DNA interactions (RUNX1, RUNX3, SRCAP, BRG1).

Main Results:

• Runx1 knockout B cells exhibited accelerated entry into S-phase upon BCR engagement.
• RUNX1 was found to regulate key genes involved in cell cycle progression and BCR signaling.
• RUNX1 interacts with chromatin remodelers SRCAP and influences the recruitment of BRG1, impacting gene transcription.
• RUNX1 modulates the expression of genes involved in immune regulation, including negative regulators of BCR signaling and IFN receptor components.

Conclusions:

• RUNX1 acts as a critical regulator of the B cell response to BCR stimulation by controlling gene expression programs.
• RUNX1's function in modulating cell cycle entry and immune-related genes suggests its involvement in maintaining B cell tolerance.
• Dysregulation of RUNX1 may contribute to aberrant B cell activation and potentially autoimmune conditions.